Clinical Trials for Pancreatic Cancer Stage IV

Find clinical trials for pancreatic cancer stage iv. Discover research opportunities and treatment options in your area.

5 Active Trials Found

Showing 5 trials on this page

Page 1 of 1

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

NCT ID: NCT05254171

This clinical trial is looking at a combination treatment for patients with metastatic pancreatic cancer, specifically using two standard drugs called nab-paclitaxel and gemcitabine, with or withou...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Heidelberg, Victoria, Australia +116 more

SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells

NCT ID: NCT04150042

The SHARON clinical trial is studying a new treatment approach for patients with advanced (stage IV) cancer who have specific genetic mutations called BRCA1, BRCA2, or PALB2. This treatment combine...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, New York, New York, United States

A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer

NCT ID: NCT04674956

This clinical trial is studying a new treatment for patients with advanced pancreatic cancer that has spread to other parts of the body (metastatic pancreatic cancer). The researchers are looking a...

Recruiting

Phase: PHASE3 Type: interventional Locations: Shanghai, Shanghai, China, Shanghai, Shanghai, China +4 more

The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer

NCT ID: NCT04406831

This clinical trial is studying the role of small molecules called microRNAs (miRNAs) in pancreatic cancer. Researchers believe that measuring specific miRNAs in the blood of patients with pancreat...

Recruiting

Type: observational Locations: Norwalk, Connecticut, United States

Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer

NCT ID: NCT06017284

This clinical trial is studying the effects of a medication called thalidomide on reducing nausea and vomiting caused by chemotherapy in patients with advanced pancreatic cancer. The goal is to see...

Recruiting

Phase: PHASE3 Type: interventional Locations: Shanghai, Shanghai, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions